October 2023 FAQs
- Do data support the use of commercially available fecal microbiota transplantation products in managing recurrent Clostridioides difficile infection?
- Is there a risk of intraoperative aspiration with the use of GLP-1 receptor agonists?
- What data exists on the use of collagenase clostridium histolyticum (CCH) for the treatment of Peyronie’s disease?